FIGURE 2-4 The rapid decline in the cost of sequencing a human genome. SOURCE: Wetterstrand 2012; Image courtesy of The National Human Genome Project. Found at:

  • Visibility and vision of the field: Both U.S. and international glycoscientists noted that relevant work taking place in a variety of disciplines may not be labeled with the term “glycobiology” and thus may not be well recognized as falling under the glycoscience umbrella. The field would benefit from having a clear picture to present to nonexperts, as well as compelling goals behind which the community could rally. Because glycoscience provides a level of data that can build from and complement genomic and proteomic information, inclusion of glycoscience components in international Human Genome Organization (HUGO) and Human Proteome Organization (HUPO) projects could help draw out these connections.9


9 One example is the Human Disease Glycomics/Proteome Initiative (HGPI) through HUPO. HGPI investigates glycosylation changes in efforts to identify possible biomarkers relevant to the diagnosis or progression of disease (see

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement